Causes of physician delay in the diagnosis of breast cancer

被引:65
作者
Goodson, WH
Moore, DH
机构
[1] Calif Pacific Med Ctr, Res Inst, Dept Surg, San Francisco, CA 94115 USA
[2] Calif Pacific Med Ctr, Geraldine Brush Canc Res Inst, San Francisco, CA 94115 USA
[3] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA
关键词
D O I
10.1001/archinte.162.12.1343
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Understanding sources of physician delay in diagnosis of breast cancer will assist efforts to expedite diagnosis. Objective: To test whether increased reliance on screening mammography has affected causes of physician delay in diagnosis of breast cancer. Design: Survey of delays in a case series. Setting: Practice specializing in breast diseases in a region with high use of screening mammography. Patients: Four hundred thirty-five consecutive patients treated for 454 breast cancers of any stage. Intervention: Customary patient care. Main Outcome Measures: Whether delay was related to how cancer was identified, patient age, individual cancer characteristics (such as tumor type), mammography reports, or physician expertise. Results: Twenty-one women (5%) were inappropriately reassured that a malignant lump was benign without biopsy, 14 women (3%) had a misread mammogram, 4 women (1%) had a misread pathologic finding, and 5 women (1%) had cancer missed by a poorly performed fine-needle aspiration biopsy. Delay was associated with a benign mammography report (relative risk, 10.8; 95% confidence interval, 5.1-22.8), a woman finding her own mass (relative risk, 3.3; 95% confidence interval, 1.8-6.2), and current hormone replacement therapy (relative risk, 3.1; 95% confidence interval, 1.2-8.5). Conclusions: The leading cause of physician delay in diagnosis of breast cancer continues to be inappropriate reassurance that a mass is benign without biopsy. Reducing delay in diagnosis will require less willingness to rely on clinical examination to decide that a mass is benign, less reliance on benign mammography reports to decide not to biopsy a mass, and a requirement that fine-needle aspiration biopsy be done by persons with demonstrated competence for the procedure.
引用
收藏
页码:1343 / 1348
页数:6
相关论文
共 36 条
[1]   PATIENTS AND DOCTORS DELAY IN PRIMARY BREAST-CANCER - PROGNOSTIC IMPLICATIONS [J].
AFZELIUS, P ;
ZEDELER, K ;
SOMMER, H ;
MOURIDSEN, HT ;
BLICHERTTOFT, M .
ACTA ONCOLOGICA, 1994, 33 (04) :345-351
[2]   Who and what influences delayed presentation in breast cancer? [J].
Burgess, CC ;
Ramirez, AJ ;
Richards, MA ;
Love, SB .
BRITISH JOURNAL OF CANCER, 1998, 77 (08) :1343-1348
[3]   As mammography use increases, are some providers omitting clinical breast examination [J].
Burns, RB ;
Freund, KM ;
Ash, AS ;
Shwartz, M ;
Antab, L ;
Hall, R .
ARCHIVES OF INTERNAL MEDICINE, 1996, 156 (07) :741-744
[4]   Reasons for delay in breast cancer diagnosis [J].
Caplan, LS ;
Helzlsouer, KJ ;
Shapiro, S ;
Wesley, MN ;
Edwards, BK .
PREVENTIVE MEDICINE, 1996, 25 (02) :218-224
[5]   SYSTEM DELAY IN BREAST-CANCER IN WHITES AND BLACKS [J].
CAPLAN, LS ;
HELZLSOUER, KJ ;
SHAPIRO, S ;
FREEDMAN, LS ;
COATES, RJ ;
EDWARDS, BK .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1995, 142 (08) :804-812
[6]  
Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P937
[7]  
CHAMBERLAIN J, 1975, LANCET, V2, P1026
[8]  
Chang JH, 2001, CANCER-AM CANCER SOC, V91, P1231, DOI 10.1002/1097-0142(20010401)91:7<1231::AID-CNCR1123>3.0.CO
[9]  
2-K
[10]   Breast cancer: delays, dilemmas, and delusions [J].
Coates, AS .
LANCET, 1999, 353 (9159) :1112-1113